BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jun CH, Ki HS, Lee HK, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma. World J Gastroenterol 2013; 19(2): 284-289 [PMID: 23345952 DOI: 10.3748/wjg.v19.i2.284]
URL: https://www.wjgnet.com/1948-5182/full/v19/i2/284.htm
Number Citing Articles
1
Andrei Florin Bloj, Ioana Hălmaciu, Bogdan Andrei Suciu, Lucian Mărginean. Treatment of Hepatocellular Carcinomas by Hepatic Transarterial Chemoembolization, Case Presentation and Review of the LiteratureActa Medica Transilvanica 2020; 25(3): 32 doi: 10.2478/amtsb-2020-0046
2
Lukas Müller, Fabian Stoehr, Aline Mähringer-Kunz, Felix Hahn, Arndt Weinmann, Roman Kloeckner. Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step GuideJournal of Hepatocellular Carcinoma 2021; : 403 doi: 10.2147/JHC.S285735
3
Yunan Wang, Zhihui Chang, Jiahe Zheng, Zhaoyu Liu, Jun Zhang. The impact of liver abscess formation on prognosis of patients with malignant liver tumors after transarterial chemoembolizationFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1256012
4
Sith Siramolpiwat, Thanachai Punjachaipornpon, Bubpha Pornthisarn, Ratha-korn Vilaichone, Soonthorn Chonprasertsuk, Anupong Tangaroonsanti, Patommatat Bhanthumkomol, Achara Phumyen, Atipat Yasiri, Mayurachat Kaewmanee. N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial ChemoembolizationDigestive Diseases and Sciences 2019; 64(11): 3337 doi: 10.1007/s10620-019-05652-0
5
Helen Blackburn, Sandra West. Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver CancerCancer Nursing 2016; 39(5): E1 doi: 10.1097/NCC.0000000000000302
6
N. Mandolfo, A. Berger, M. Hammer. Glycemic variability in patients with gastrointestinal cancer: An integrative reviewEuropean Journal of Oncology Nursing 2020; 48: 101797 doi: 10.1016/j.ejon.2020.101797
7
HIROKI NISHIKAWA, YUKIO OSAKI, RYUICHI KITA, TORU KIMURA, YOSHIAKI OHARA, HARUHIKO TAKEDA, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, HIDEYUKI KOMEKADO, SHUHEI NISHIGUCHI. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaOncology Reports 2014; 31(1): 65 doi: 10.3892/or.2013.2845
8
Rohan Chaminda Siriwardana, Madunil Anuk Niriella, Anuradha Supun Dassanayake, Chandika Anuradha Habarakada Liyanage, Angappulige Upasena, Chandra Sirigampala, Hithanadura Janaka de Silva. Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysisBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0329-8
9
Yi Pan, Rui Chang, Zhonglin He, Ming Hong. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?Medicine 2021; 100(14): e25360 doi: 10.1097/MD.0000000000025360
10
Meredith C. Mason, Nader N. Massarweh, Aitua Salami, Mark A. Sultenfuss, Daniel A. Anaya. Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinomaHPB 2015; 17(12): 1137 doi: 10.1111/hpb.12487
11
Seung Ji Kang, Uh Jin Kim, Seong Eun Kim, Joon Hwan An, Mi Ok Jang, Dae-Seong Myung, Kyung-Hwa Park, Sook-In Jung, Sung Bum Cho, Hee-Chang Jang, Young Eun Joo. Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular CarcinomaDisease Markers 2018; 2018: 1 doi: 10.1155/2018/9120878
12
Jinpeng Li, Congcong Shi, Jutian Shi, Jinlong Song, Nan Wang. Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinomaMedicine 2021; 100(44): e27636 doi: 10.1097/MD.0000000000027636
13
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Phurich Janjindamai, Surasit Akkakrisee, Teerha Piratvisuth, Alan Geater. Decision-Making Scoring System for the Repetition of Conventional Transarterial Chemoembolization in Patients With Inoperable Hepatocellular CarcinomaClinical and Translational Gastroenterology 2022; 13(7): e00506 doi: 10.14309/ctg.0000000000000506
14
Muhammet Arslan, Serkan Degirmencioglu. Risk Factors for Postembolization Syndrome After Transcatheter Arterial ChemoembolizationCurrent Medical Imaging Formerly Current Medical Imaging Reviews 2019; 15(4): 380 doi: 10.2174/1573405615666181122145330
15
Chandan K. Kedarisetty, Sipra Bal, Subhashree Parida, Mayank Jain, Ajeet S. Bhadoria, Joy Varghese, Jayanthi Venkataraman. Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center ExperienceJournal of Clinical and Experimental Hepatology 2021; 11(3): 299 doi: 10.1016/j.jceh.2020.10.007
16
Chien‐Wei Peng, Wei Teng, Yi‐Chung Hsieh, Wen‐Juei Jeng, Chien‐Hao Huang, Kar‐Wai Lui, Chen‐Fu Hung, Yi‐Cheng Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen. Postembolization fever after transarterial chemoembolization is a sign of unfavorable therapeutic response in hepatocellular carcinoma patientsAdvances in Digestive Medicine 2020; 7(2): 83 doi: 10.1002/aid2.13182
17
Anan Abu Rmilah, Mohammad N. Qrareya, Chad Fleming, Adham K. Alkurashi, Scott Nyberg, Michael Leise, James C. Andrews. Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome After Bland Hepatic Artery Embolization for Hepatic MalignancyAmerican Journal of Roentgenology 2022; 218(6): 1030 doi: 10.2214/AJR.21.26806
18
Adam Hatzidakis, Lukas Müller, Miltiadis Krokidis, Roman Kloeckner. Local and Regional Therapies for Hepatocellular Carcinoma and Future CombinationsCancers 2022; 14(10): 2469 doi: 10.3390/cancers14102469
19
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914